デフォルト表紙
市場調査レポート
商品コード
1681611

スペクトルCT市場規模、シェア、成長分析:製品タイプ別、技術別、エンドユーザー別、地域別 - 産業予測 2025~2032年

Spectral Computed Tomography Market Size, Share, and Growth Analysis, By Product Type (Spiral CT, Electron Beam Tomography), By Technology (Dual-Layer Detector, Gemstone Spectral Imaging Detector), By End User, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
スペクトルCT市場規模、シェア、成長分析:製品タイプ別、技術別、エンドユーザー別、地域別 - 産業予測 2025~2032年
出版日: 2025年03月08日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

スペクトルCTの市場規模は2023年に84億米ドル、予測期間(2025-2032年)のCAGRは7.6%で、2024年の90億4,000万米ドルから2032年には162億4,000万米ドルに成長する見通し。

デュアルエネルギーCT(DECT)は、2つのエネルギースペクトルを組み合わせることで、物理的な現実を物質密度に基づく詳細な画像に変換する、医用画像診断における重要なブレークスルーを意味します。この先端技術は、組織特性の微細な違いを捉える能力により、従来のCTスキャナーを凌駕する優れた組織組成および構造解析を提供します。DECTは洗練されたコンピューターアルゴリズムを利用し、画像品質と分析精度を向上させることで、ヘルスケア専門家がより多くの情報に基づいた診断と治療の決定を下せるようにします。DECTのハイテク機能は画像診断の結果を向上させ、患者ケアの向上につながります。この革新的なアプローチは診断精度を向上させるだけでなく、治療計画を最適化し、DECTを進化する医療画像技術における重要なツールとして確固たる地位を築いています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析
  • 規制情勢
  • ケーススタディ
  • 技術の進歩

スペクトルCT市場規模:製品タイプ別& CAGR(2025-2032)

  • 市場概要
  • スパイラルCT
  • 電子線トモグラフィー
  • マルチスライスCT

スペクトルCT市場規模:技術別& CAGR(2025-2032)

  • 市場概要
  • デュアルレイヤー検出器
  • ガーネットスペクトル画像検出器

スペクトルCT市場規模:エンドユーザー別& CAGR(2025-2032)

  • 市場概要
  • 病院
  • 個人クリニック
  • 診断および画像診断センター
  • 学術機関および研究センター
  • その他

スペクトルCT市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • Siemens Healthineers(Germany)
  • GE Healthcare(United States)
  • Koninklijke Philips N.V.(Netherlands)
  • Canon Medical Systems Corporation(Japan)
  • FUJIFILM Holdings Corporation(Japan)
  • Shimadzu Corporation(Japan)
  • Koning Corporation(United States)
  • Neusoft Medical Systems Co., Ltd.(China)
  • Planmeca Oy(Finland)
  • Stryker Corporation(United States)
  • Carestream Health(United States)
  • Hitachi High-Tech Corporation(Japan)
  • Samsung Medison(South Korea)
  • Agfa-Gevaert Group(Belgium)
  • United Imaging Healthcare(China)
  • Baker Hughes Company(Waygate Technologies)(United States)
  • Carl Zeiss AG(Germany)
  • Yxlon International GmbH(Comet Group)(Germany)
  • Wenzel Group(Germany)
  • Nikon Metrology NV(Nikon Corporation)(Japan)

結論と提言

目次
Product Code: SQMIG35A2794

Spectral Computed Tomography Market size was valued at USD 8.4 billion in 2023 and is poised to grow from USD 9.04 billion in 2024 to USD 16.24 billion by 2032, growing at a CAGR of 7.6% during the forecast period (2025-2032).

Dual-energy computed tomography (DECT) represents a significant breakthrough in medical imaging, combining two energy spectrums to transform physical realities into detailed images based on material density. This advanced technology surpasses traditional CT scanners by providing superior tissue composition and structure analysis, thanks to its ability to capture minute differences in tissue characteristics. DECT utilizes sophisticated computer algorithms that enhance imaging quality and analytical precision, enabling healthcare professionals to make more informed diagnostic and treatment decisions. The high-tech capabilities of DECT offer enhanced imaging outcomes, translating into better patient care. This innovative approach not only improves diagnostic accuracy but also optimizes treatment planning, firmly establishing DECT as a critical tool in the evolving landscape of medical imaging technology.

Top-down and bottom-up approaches were used to estimate and validate the size of the Spectral Computed Tomography market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Spectral Computed Tomography Market Segments Analysis

Global Spectral Computed Tomography Market is segmented by Product Type, Technology, End User and region. Based on Product Type, the market is segmented into Spiral CT, Electron Beam Tomography and Multi-Slice Computed Tomography. Based on Technology, the market is segmented into Dual-Layer Detector and Gemstone Spectral Imaging Detector. Based on End User, the market is segmented into Hospitals, Private Clinics, Diagnostic and Imaging Centres, Academic Institutes and Research Centres and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Spectral Computed Tomography Market

The Spectral Computed Tomography (CT) market is experiencing remarkable expansion, primarily fueled by its potential for improved diagnostic precision. Unlike traditional CT scans, spectral CT technology captures data across various energy levels, offering a more granular analysis of tissue composition and material characterization. This innovative approach empowers healthcare providers to gain deeper insights into the fundamental properties of tissues, facilitating better detection and evaluation of diverse medical conditions. By leveraging the ability to distinguish between materials based on their spectral signatures, spectral CT enhances accuracy, especially in intricate cases where conventional imaging may not suffice. This advanced understanding of tissue composition not only aids in early and precise diagnoses but also significantly enhances patient outcomes, ultimately fostering more personalized and effective medical treatments.

Restraints in the Spectral Computed Tomography Market

Although spectral computed tomography (CT) holds great promise for delivering superior diagnostic insights, there remains a limited amount of clinical evidence that substantiates its advantages over traditional CT in particular use cases. This gap in robust clinical data, which fails to clearly outline the specific benefits of spectral CT in various medical situations, could cause healthcare providers to be hesitant in adopting this advanced technology. As a result, the lack of convincing evidence may impede the widespread acceptance and integration of spectral CT into routine medical practice, ultimately hindering its growth in the market.

Market Trends of the Spectral Computed Tomography Market

The Spectral Computed Tomography (CT) market is witnessing a notable trend towards reducing radiation doses, driven by a growing emphasis on patient safety and minimizing exposure during medical imaging. Recent advancements in spectral CT technology, particularly dual-energy imaging, have enhanced tissue characterization and visualization capabilities while significantly lowering the radiation dose required for scans. This innovative approach leverages multiple energy spectra to optimize imaging protocols, allowing for more comprehensive diagnostic information without compromising patient safety. As a result, spectral CT is becoming increasingly crucial in imaging for vulnerable populations and patients needing frequent scans, positioning the market for robust growth in the coming years.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies
  • Technological Advancement

Global Spectral Computed Tomography Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Spiral CT
  • Electron Beam Tomography
  • Multi-Slice Computed Tomography

Global Spectral Computed Tomography Market Size by Technology & CAGR (2025-2032)

  • Market Overview
  • Dual-Layer Detector
  • Gemstone Spectral Imaging Detector

Global Spectral Computed Tomography Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Private Clinics
  • Diagnostic and Imaging Centres
  • Academic Institutes and Research Centres
  • Others

Global Spectral Computed Tomography Market Size & CAGR (2025-2032)

  • North America (Product Type, Technology, End User)
    • US
    • Canada
  • Europe (Product Type, Technology, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Technology, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Technology, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Technology, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koninklijke Philips N.V. (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Canon Medical Systems Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • FUJIFILM Holdings Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Shimadzu Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Koning Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Neusoft Medical Systems Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Planmeca Oy (Finland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Stryker Corporation (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carestream Health (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hitachi High-Tech Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Samsung Medison (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Agfa-Gevaert Group (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • United Imaging Healthcare (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baker Hughes Company (Waygate Technologies) (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carl Zeiss AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Yxlon International GmbH (Comet Group) (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Wenzel Group (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nikon Metrology NV (Nikon Corporation) (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations